TGA approves first Australian commercial CAR-T manufacturing site – bringing faster access to eligible Australians with life-threatening blood cancers
12 February 2021 • Kymriah® (tisagenlecleucel)[pronounced kim-RY-uh], a chimeric antigen receptor T cell (CAR-T) one-time treatment, will be the first commercially approved CAR-T therapy to be manufactured in Australia • Providing manufacturing capabilities in Australia will help reduce…
New appointments at Biointelect
12 February 2021 Biointelect has made several new appointments to its Sydney and Melbourne-based teams as it experiences strong growth across all its three main consulting workstreams: R&D strategy and planning, biotech commercialisation and strategic market access, health…
First-hand experience sparks Rhinomed to develop high comfort swab
Posted 10 December 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. In April this year, as the world came to grips with the global COVID-19 pandemic, Rhinomed CEO Michael…
Monash University partners with HuiKang Bio-Tech to develop new class of anti-infectives
7 December 2020 Monash University has announced a collaboration with leading protein and peptide experts, HuiKang Bio-Tech, to develop a new class of anti-infectives. The collaboration is being led by Professor Ray Norton from the Monash Institute of…
Stephens Lawyers & Consultants: ACCC Enforcement Proceedings – Unfair Contract Terms
1 December 2020 From Katarina Klaric (Principal & Director) and Peter Divitcos (Lawyer), Stephens Lawyers & Consultants Standard form contracts are being subjected to increased scrutiny for unfair contract terms by regulators. On-line terms and conditions are of…
mexec uses COVID grant to assist industry job seekers
Posted 26 November 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. With companies across the industry forced to let staff go, Marilyn Jones knew that 2020 was…
Even from a distance, Commercial Eyes is thriving
Posted 12 November 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. This story was submitted by Andrew Carter, Managing Director Do you remember saying – “I catch…
“It’s been a big 12 months for Crux Biolabs”
Posted 29 October 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. This story was submitted by CEO Catherine Osborne PhD GAICD. It has a been a big…
Electronic Marketing and the Australian Spam Act 2003 – Legal Update – August 2020
Date Posted – 21 October 2020 Electronic marketing campaigns play a significant part in business’s overall marketing strategy for the promotion of their business, goods and services. They provide an effective tool for the delivery of marketing messages…
Starpharma VivaGel® BV secures TGA approval for prevention of BV
8 October 2020 Release date: 25 September 2020 Highlights: VivaGel® BV approved claims in Australia have been expanded to also include prevention of recurrent bacterial vaginosis (BV) VivaGel® BV is the only OTC pharmacy product in Australia to…
4DMedical Receives TGA Approval For XV Lung Ventilation Analysis Software (XV LVAS)
8 October 2020 Release date: 30 September 2020 Highlights The Australian Therapeutic Goods Administration (TGA) has approved 4DMedical’s XV Lung Ventilation Analysis Software (XV LVAS) for inclusion in the Australian Register of Therapeutic Goods (ARTG) XV LVAS utilises…
Tricycle Developments love to solve problems that improve lives and create positive impact
Posted 8 October 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. Tricycle Developments love to solve problems that improve lives and create a positive impact. Located in Melbourne, Tricycle provides design and…
